Boundless Bio (BOLD) Prepaid Assets (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Prepaid Assets of $1.8 million for Q1 2026, down 16.2% year-over-year from $2.1 million in Q1 2025, and down 12.86% quarter-over-quarter from $2.0 million in Q4 2025.
Boundless Bio (BOLD) Prepaid Assets (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Prepaid Assets for 4 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Prepaid Assets fell 16.2% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (down 16.2% YoY), while the FY2025 annual figure was $2.0 million, down 10.81% from the prior year.
- Prepaid Assets retreated to $1.8 million in Q1 2026 per BOLD's latest filing, from $2.0 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.3 million in Q1 2024 and bottomed at $1.8 million in Q1 2026.
- Historically, Prepaid Assets has averaged $3.1 million across 4 years, with a median of $2.6 million in 2025.
- On a YoY basis, Prepaid Assets climbed as much as 10.81% in 2025 and fell as far as 71.01% in 2025.
- Boundless Bio's Prepaid Assets stood at $3.5 million in 2023, then plunged by 34.07% to $2.3 million in 2024, then slipped by 10.81% to $2.0 million in 2025, then retreated by 12.86% to $1.8 million in 2026.
- Business Quant data shows BOLD's Prepaid Assets at $1.8 million in Q1 2026, $2.0 million in Q4 2025, and $2.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.95 Bn | 132.10 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.71 Bn | 78.72 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.71 Bn | 60.52 Bn | 1.37 Bn |
| 4 | Moderna | 60.45 Bn | 55.31 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.24 Bn | 37.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.80 Bn | 28.49 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.64 Bn | 10.25 Bn | 668.28 Mn |
| 8 | Insmed | 27.61 Bn | 26.45 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.26 Bn | 26.42 Bn | - |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Mar 31, 2026 | 1.77 Mn |
| Dec 31, 2025 | 2.03 Mn |
| Sep 30, 2025 | 2.59 Mn |
| Jun 30, 2025 | 2.54 Mn |
| Mar 31, 2025 | 2.11 Mn |
| Dec 31, 2024 | 2.28 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.84 Mn |
| Mar 31, 2024 | 7.28 Mn |
| Dec 31, 2023 | 3.45 Mn |